Skip to main content
. 2002 Oct 21;2002(4):CD003913. doi: 10.1002/14651858.CD003913

EORTC 26751.

Methods RCT
Participants 116
 ‐Malignant glioma
 ‐Optimal resection
Interventions CT + RT vs RT
 ‐CCNU 130mg/m2 oral
 % VM‐26 60mg/m2 iv q 6 wks
Outcomes Survival
 Recurrence‐free survival
Notes 1975‐1978
 1st random
Risk of bias
Bias Authors' judgement Support for judgement
Allocation concealment? Low risk A ‐ Adequate